pubmed-article:7914962 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7914962 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:7914962 | lifeskim:mentions | umls-concept:C0028365 | lld:lifeskim |
pubmed-article:7914962 | lifeskim:mentions | umls-concept:C0042105 | lld:lifeskim |
pubmed-article:7914962 | lifeskim:mentions | umls-concept:C0183512 | lld:lifeskim |
pubmed-article:7914962 | lifeskim:mentions | umls-concept:C1947917 | lld:lifeskim |
pubmed-article:7914962 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
pubmed-article:7914962 | pubmed:issue | 8922 | lld:pubmed |
pubmed-article:7914962 | pubmed:dateCreated | 1994-9-22 | lld:pubmed |
pubmed-article:7914962 | pubmed:abstractText | Biliary stents are liable to clog. We investigated whether a choleretic plus an antibiotic could delay clogging. 20 consecutive patients with a malignant biliary stricture were randomised after endoscopic insertion of a polyethylene stent to receive ursodeoxycholic acid plus norfloxacin (13-15 mg/kg and 400 mg, daily) or conservative treatment. The drug combination was associated with: a longer median patency of first (49 vs 6 weeks) and all stents (38 vs 7 weeks); a prolonged median survival (67 vs 18 weeks); and a shorter mean hospital stay (0.2 vs 1.0 days per week of survival). Thus ursodeoxycholic acid plus norfloxacin may prevent stent clogging. | lld:pubmed |
pubmed-article:7914962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7914962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7914962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7914962 | pubmed:language | eng | lld:pubmed |
pubmed-article:7914962 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7914962 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:7914962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7914962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7914962 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7914962 | pubmed:month | Aug | lld:pubmed |
pubmed-article:7914962 | pubmed:issn | 0140-6736 | lld:pubmed |
pubmed-article:7914962 | pubmed:author | pubmed-author:SilvainCC | lld:pubmed |
pubmed-article:7914962 | pubmed:author | pubmed-author:BeauchantMM | lld:pubmed |
pubmed-article:7914962 | pubmed:author | pubmed-author:BessonII | lld:pubmed |
pubmed-article:7914962 | pubmed:author | pubmed-author:IngrandPP | lld:pubmed |
pubmed-article:7914962 | pubmed:author | pubmed-author:BarriosOO | lld:pubmed |
pubmed-article:7914962 | pubmed:author | pubmed-author:de... | lld:pubmed |
pubmed-article:7914962 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7914962 | pubmed:day | 27 | lld:pubmed |
pubmed-article:7914962 | pubmed:volume | 344 | lld:pubmed |
pubmed-article:7914962 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7914962 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7914962 | pubmed:pagination | 581-2 | lld:pubmed |
pubmed-article:7914962 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:7914962 | pubmed:meshHeading | pubmed-meshheading:7914962-... | lld:pubmed |
pubmed-article:7914962 | pubmed:meshHeading | pubmed-meshheading:7914962-... | lld:pubmed |
pubmed-article:7914962 | pubmed:meshHeading | pubmed-meshheading:7914962-... | lld:pubmed |
pubmed-article:7914962 | pubmed:meshHeading | pubmed-meshheading:7914962-... | lld:pubmed |
pubmed-article:7914962 | pubmed:meshHeading | pubmed-meshheading:7914962-... | lld:pubmed |
pubmed-article:7914962 | pubmed:meshHeading | pubmed-meshheading:7914962-... | lld:pubmed |
pubmed-article:7914962 | pubmed:meshHeading | pubmed-meshheading:7914962-... | lld:pubmed |
pubmed-article:7914962 | pubmed:meshHeading | pubmed-meshheading:7914962-... | lld:pubmed |
pubmed-article:7914962 | pubmed:meshHeading | pubmed-meshheading:7914962-... | lld:pubmed |
pubmed-article:7914962 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:7914962 | pubmed:articleTitle | Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin. | lld:pubmed |
pubmed-article:7914962 | pubmed:affiliation | Hepatology Unit, University Hospital, Poitiers, France. | lld:pubmed |
pubmed-article:7914962 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7914962 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:7914962 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7914962 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7914962 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7914962 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7914962 | lld:pubmed |